S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
Sinema took Wall Street money while killing tax on investors
Apple’s Next “Star Product” Could Replace The iPhone? (Ad)pixel
Expanded IRS free-file system one step closer in Dems' bill
Climate bill: Could coal communities shift to nuclear?
High oil prices help Saudi Aramco earn $88B in first half
Apple’s Next “Star Product” Could Replace The iPhone? (Ad)pixel
'Everyone's Got a Story of How the Healthcare System Has Fallen Short.' This Founder Is on a Mission to Change That.
Germans urged to cap heat in offices this winter to save gas
Former Deutsche Bank Co-CEO Anshu Jain dies
US Dollar Replaced By "Biden Bucks"? (Ad)
S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
Sinema took Wall Street money while killing tax on investors
Apple’s Next “Star Product” Could Replace The iPhone? (Ad)pixel
Expanded IRS free-file system one step closer in Dems' bill
Climate bill: Could coal communities shift to nuclear?
High oil prices help Saudi Aramco earn $88B in first half
Apple’s Next “Star Product” Could Replace The iPhone? (Ad)pixel
'Everyone's Got a Story of How the Healthcare System Has Fallen Short.' This Founder Is on a Mission to Change That.
Germans urged to cap heat in offices this winter to save gas
Former Deutsche Bank Co-CEO Anshu Jain dies
US Dollar Replaced By "Biden Bucks"? (Ad)
S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
Sinema took Wall Street money while killing tax on investors
Apple’s Next “Star Product” Could Replace The iPhone? (Ad)pixel
Expanded IRS free-file system one step closer in Dems' bill
Climate bill: Could coal communities shift to nuclear?
High oil prices help Saudi Aramco earn $88B in first half
Apple’s Next “Star Product” Could Replace The iPhone? (Ad)pixel
'Everyone's Got a Story of How the Healthcare System Has Fallen Short.' This Founder Is on a Mission to Change That.
Germans urged to cap heat in offices this winter to save gas
Former Deutsche Bank Co-CEO Anshu Jain dies
US Dollar Replaced By "Biden Bucks"? (Ad)
S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
Sinema took Wall Street money while killing tax on investors
Apple’s Next “Star Product” Could Replace The iPhone? (Ad)pixel
Expanded IRS free-file system one step closer in Dems' bill
Climate bill: Could coal communities shift to nuclear?
High oil prices help Saudi Aramco earn $88B in first half
Apple’s Next “Star Product” Could Replace The iPhone? (Ad)pixel
'Everyone's Got a Story of How the Healthcare System Has Fallen Short.' This Founder Is on a Mission to Change That.
Germans urged to cap heat in offices this winter to save gas
Former Deutsche Bank Co-CEO Anshu Jain dies
US Dollar Replaced By "Biden Bucks"? (Ad)
EPA:SAN

Sanofi - SAN Stock Forecast, Price & News

€85.46
+0.71 (+0.84%)
(As of 08/12/2022 12:00 AM ET)
Add
Compare
Today's Range
€83.81
€87.46
50-Day Range
€84.75
€101.00
52-Week Range
€63.09
€92.97
Volume
4.19 million shs
Average Volume
3.05 million shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
€106.30
SAN stock logo

About Sanofi (EPA:SAN) Stock

Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antibodies; products for multiple sclerosis, neurology, other inflammatory diseases, immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes; and cardiovascular and established prescription products. It also supplies poliomyelitis, pertussis, and hib pediatric vaccines; and influenza, adult booster, meningitis, and travel and endemic vaccines. In addition, the company offers allergy, cough and cold, pain, liver care, physical and mental wellness, probiotics, digestive, and nutritional products; and other products, such as daily body lotions, anti-itch products, moisturizing and soothing lotions, and body and foot creams, as well as powders for eczema. Further, it has various pharmaceutical products and vaccines in development stage. Sanofi has collaboration agreement with GlaxoSmithKline to develop a recombinant Covid-19 vaccine; and a research collaboration with Stanford University School of Medicine to advance the understanding of immunology and inflammation through open scientific exchange. It also has a collaboration and license option agreement with Prellis Biologics, Inc. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was founded in 1973 and is headquartered in Paris, France.

Receive SAN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sanofi and its competitors with MarketBeat's FREE daily newsletter.

SAN Stock News Headlines

Form 6-K Sanofi For: Jun 30 - StreetInsider.com
Sanofi Offloads 17 Products To Neuraxpharm
See More Headlines
Receive SAN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sanofi and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Drug Manufacturers - Major
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
95,442
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
€106.30
High Stock Price Forecast
€124.00
Low Stock Price Forecast
€80.00
Forecasted Upside/Downside
+24.4%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
1 Analysts

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Optionable
Beta
N/A

Key Executives

  • Mr. Paul Hudson (Age 55)
    CEO & Director
    Comp: $5.64M
  • Mr. Jean-Baptiste Chasseloup de Chatillon (Age 57)
    Exec. VP & CFO
  • Mr. Laurent Gilhodes
    Principal Accounting Officer and VP of Corp. Accounting
  • Mr. Bruno Ménard
    Chief Information officer
  • Dr. Josephine Fubara
    Chief Science Officer of Consumer Health Care
  • Eva Schaefer-Jansen
    Head of Investor Relations
  • Mr. Dante Beccaria
    Global Compliance Officer & VP
  • Mr. Roy Papatheodorou (Age 44)
    Exec. VP, Gen. Counsel and Head of Legal, Ethics & Bus. Integrity
  • Mr. Josep Catlla
    Head of Communications
  • Mr. Pierre Chancel (Age 65)
    Sr. VP of Global Diabetes and Sr. VP of Global Marketing













SAN Stock - Frequently Asked Questions

Should I buy or sell Sanofi stock right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Sanofi in the last year. There are currently 1 hold rating for the stock. The consensus among Wall Street analysts is that investors should "hold" SAN shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SAN, but not buy additional shares or sell existing shares.
View SAN analyst ratings
or view top-rated stocks.

What is Sanofi's stock price forecast for 2022?

1 equities research analysts have issued 1-year price objectives for Sanofi's shares. Their SAN share price forecasts range from €80.00 to €124.00. On average, they expect the company's share price to reach €106.30 in the next twelve months. This suggests a possible upside of 24.4% from the stock's current price.
View analysts price targets for SAN
or view top-rated stocks among Wall Street analysts.

How have SAN shares performed in 2022?

Sanofi's stock was trading at €88.58 at the start of the year. Since then, SAN stock has decreased by 3.5% and is now trading at €85.46.
View the best growth stocks for 2022 here
.

What other stocks do shareholders of Sanofi own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Sanofi investors own include Skechers U.S.A. (SKX), NVIDIA (NVDA), Sanofi (SNY), Intel (INTC), Salesforce (CRM), Bank of America (BAC), Tronox (TROX), Advanced Micro Devices (AMD) and Tesla (TSLA).

What is Sanofi's stock symbol?

Sanofi trades on the EPA under the ticker symbol "SAN."

What is Sanofi's stock price today?

One share of SAN stock can currently be purchased for approximately €85.46.

How many employees does Sanofi have?

The company employs 95,442 workers across the globe.

How can I contact Sanofi?

Sanofi's mailing address is 54 rue la Boetie, PARIS, 75008, France. The official website for the company is en.sanofi.com. The company can be reached via phone at +33-1-53774000.

This page (EPA:SAN) was last updated on 8/14/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.